Beazer Homes USA Inc.'s (BZH, $18.72, +$1.93, +11.47%) fiscal second-quarter loss narrowed as the home builder's revenue jumped and it continued to see improvements in home closings, backlogs and margins.
ATLANTA, May 14, 2013 (BUSINESS WIRE) -- Beazer Homes USA, Inc. (NYSE:BZH) (www.beazer.com) will present at the J.P. Morgan Homebuilding and Building Products Conference in New York, NY on Tuesday, May 21, 2013 at 1:25 pm EDT.
ATLANTA--(BUSINESS WIRE)--Beazer Homes USA, Inc. (NYSE: BZH) (www.beazer.com) has scheduled the release of its financial results for the quarter ended March 31, 2013 on Thursday, May 2, 2013 before the open of the market.
Beazer Homes USA logo Equities research analysts at UBS AG lifted their price target on shares of Beazer Homes USA (NYSE: BZH) from $25.00 to $28.00 in a research note issued to investors on Friday, Analyst Ratings Network reports.
Beazer Homes USA, Inc. (NYSE: BZH) (www.beazer.com) today announced the promotion and appointment of Ekaterina "Katya" Schwallie to Vice President, Treasurer and Financial Planning and Analysis, assuming an expanded role after Jeffrey Hoza, the ...
The company's quarterly revenue was up 50.3% on a year-over-year basis. On average, analysts predict that Beazer Homes USA will post $-2.06 earnings per share for the current fiscal year.
Globus Medical Inc (NYSE:GMED) shares jumped 4.53% and closed at $16.39 in the last trading session. The company on May 2 announced its financial results for the quarter ended March 31, 2013.
Beazer Homes USA Inc. (NYSE: BZH) - which designs, sells and builds single- and multi-family homes in the United States - was trading at $18, up 7.2 percent during Pre-Market on 12,650 traded shares.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.